Loading resource…

Waichi Wong, MD
Chronic kidney disease (CKD) affects over 800 million individuals globally, leading to significant health issues. The document outlines how RAAS inhibitors have been pivotal in slowing CKD progression and improving patient outcomes. It also reviews the emergence of new therapies that provide additional benefits for kidney and cardiovascular health. Furthermore, it addresses the advancements in prognostic assessment methods, although their integration into clinical practice is still a work in progress.
No account needed